respiratori
tract
infect
caus
chlamydia
implic
pathogenesi
asthma
virus
demonstr
associ
asthma
epidemiolog
least
two
way
fig
first
infanc
certain
virus
implic
potenti
respons
incept
asthmat
phenotyp
second
patient
particularli
children
establish
asthma
viral
upper
respiratori
tract
infect
play
signific
role
produc
acut
exacerb
airway
obstruct
may
result
frequent
outpati
visit
hospit
articl
review
two
area
focus
first
mechan
viru
infect
may
lead
develop
asthma
infant
children
second
mechan
viru
infect
may
produc
acut
asthmat
symptom
patient
alreadi
establish
diseas
support
nih
grant
infect
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
receiv
much
attent
predilect
produc
pattern
symptom
term
bronchioz
parallel
mani
featur
childhood
adult
respiratori
syncyti
viru
caus
episod
estim
age
year
children
infect
virusn
infect
involv
lower
respiratori
age
nearli
children
infect
rsv
least
children
age
month
prone
develop
lower
respiratori
tract
symptom
suggest
development
compon
eg
lung
immunolog
matur
may
involv
relationship
rsv
infect
first
year
life
subsequ
develop
asthmat
phenotyp
subject
much
interest
well
controversi
variat
report
longitudin
outcom
eg
recurr
wheez
measur
airway
hyperrespons
diagnosi
asthma
appear
influenc
mostli
criteria
use
defin
bronchiol
criteria
includ
type
viru
produc
symptom
addit
rsv
virus
may
contribut
develop
bronchiol
age
group
could
piv
coronaviru
influenzaviru
rhinviru
age
time
infect
natur
sever
symptom
requir
inclus
final
characterist
studi
popul
commun
versu
hospitalbas
studi
design
retrospect
versu
prospect
number
longterm
prospect
studi
children
admit
hospit
document
rsvinduc
bronchiol
shown
experi
wheez
first
year
initi
ill
still
wheez
year
later
approxim
continu
wheez
year
addit
insight
area
recent
provid
result
llyear
prospect
studi
involv
children
enrol
birth
follow
develop
lower
respiratori
tract
ill
lri
first
year
life
evalu
presenc
absenc
physiciandiagnos
asthma
histori
current
wheez
age
importantli
lung
function
evalu
first
month
life
subset
children
prior
develop
document
lri
first
year
life
pneumonia
document
radiograph
signific
lri
without
pneumonia
respiratori
syncyti
viru
piv
identifi
respect
subject
pneumonia
respect
subject
lri
age
physiciandiagnos
asthma
present
subject
pneumonia
lri
lri
respect
age
valu
increas
respect
mean
maximum
volum
function
residu
capac
valu
lri
lower
children
pneumonia
lri
children
lri
valu
continu
lower
age
age
forc
expiratori
volum
second
fevl
fef
record
similar
group
relationship
persist
interestingli
despit
persist
lower
baselin
lung
function
pneumonia
lri
group
mani
deficit
markedli
complet
reduc
follow
administr
albuterol
second
report
followup
larg
cohort
children
demonstr
risk
frequent
three
episod
wheez
per
year
infrequ
three
episod
wheez
per
year
wheez
relat
rsv
lower
respiratori
ill
decreas
markedli
age
becam
nonsignific
age
data
suggest
although
rsv
infect
contribut
substanti
express
asthmat
phenotyp
factor
eg
genet
environment
development
appear
contribut
well
either
term
initi
express
modif
phenotyp
time
addit
premorbid
lung
function
influenc
atopi
develop
asthmat
phenotyp
relationship
viral
infect
also
evalu
interact
two
factor
appear
bidirect
dynam
atop
state
influenc
lower
airway
respons
viral
infect
viral
infect
influenc
develop
allergen
interact
occur
individu
expos
simultan
allergen
atopi
defin
genet
predisposit
preferenti
develop
immunoglobulin
e
antibodi
respons
varieti
environment
allergen
state
previous
atopi
consid
risk
factor
develop
childhood
asthma
influenc
pattern
respons
follow
viral
infect
interest
mani
investig
group
also
suggest
atopi
could
signific
predispos
factor
develop
acut
bronchiol
rsv
epid
e
c
although
found
children
like
persist
wheez
born
atop
other
found
person
atopi
preval
symptomat
children
brnchioliti
other
found
document
rsv
bronchiol
significantli
increas
child
chanc
versu
control
subsequ
develop
ige
antibodi
lymphocyt
prolif
food
aeroallergen
respiratori
syncyti
viru
infect
may
interact
immunoinflammatori
mechan
involv
immedi
hypersensit
respons
number
first
suggest
virus
capabl
infect
lower
airway
epithelium
may
lead
enhanc
absorpt
aeroallergen
across
airway
wall
predispos
subsequ
sensitizatin
second
rsvspecif
ige
antibodi
format
may
lead
mastcellmedi
releas
within
airway
result
develop
bronchospasm
ingress
eoinophil
respiratori
syncyti
viru
belong
famili
paramyxovirida
genera
pneumoviru
differenti
two
serolog
subgroup
bm
gene
potenti
gene
product
g
attach
f
fusion
protein
major
su
ace
glycoprotein
neutral
antibodi
direct
interestingli
vitro
experi
note
g
protein
elicit
predomin
respons
wherea
f
protein
produc
predomin
thl
respons
mice
test
activ
cell
recogn
individu
rsv
protein
vivo
virusspecif
tcell
line
produc
use
recombin
vaccinia
virus
express
either
g
f
protein
follow
passiv
transfer
cell
line
naiv
recipi
subsequ
intranas
inocul
rsv
mice
receiv
gspecif
cell
sever
ill
character
lung
hemorrhag
pulmonari
neutrophil
recruit
intens
pulmonari
experi
interest
base
advers
clinic
respons
note
mani
infant
receiv
formalininactiv
rsv
vaccin
subsequ
becam
infect
rsv
intrigu
observ
regard
rsv
influenc
thl
respons
recent
expand
roman
et
evalu
hospit
infant
month
acut
lower
respiratori
tract
infect
caus
rsv
compar
control
infant
peripher
blood
cell
infect
children
suppress
ifn
product
ex
vivo
although
product
also
decreas
ifni
ratio
significantli
increas
renzi
et
p
prospect
follow
infant
hospit
bronchiol
obtain
blood
sampl
time
ill
month
later
found
immun
respons
acut
infect
correl
longterm
pulmonari
outcom
blood
lymphocyt
obtain
time
bronchiol
produc
less
ifn
ex
vivo
respons
respons
furinu
antigen
children
went
develop
pattern
recurr
final
lower
ifni
product
time
bronchiol
demonstr
indic
reduc
pulmonari
function
increas
respons
histamin
month
bronchiol
relat
develop
asthma
bronchiol
infant
contrast
group
note
increas
level
ifni
respiratori
tract
secret
rsv
ill
infant
children
bronchiol
recurr
wheez
compar
upper
respiratori
tract
symptom
unfortun
studi
report
thu
far
pattern
cytokin
respons
infant
prior
infect
evalu
beg
question
observ
result
may
caus
effect
comprehens
evalu
relationship
among
viru
infect
atopi
cytokin
dysregul
thl
imbal
immun
system
lung
development
compon
rat
model
virusinduc
airway
dysfunct
studi
extens
l
model
infect
piv
type
critic
development
time
period
anim
wean
week
age
oppos
neonat
day
adult
produc
chronic
week
follow
infect
episod
revers
airway
inflamm
remodel
associ
alter
airway
physiolog
increas
resist
rnethacholin
respons
resembl
human
asthma
high
brown
norway
strain
low
strain
igeantibodi
produc
tempor
progress
asthmalik
syndrom
associ
thl
imbal
within
lung
develop
significantli
attenu
exogen
administr
prior
viral
infect
brown
norway
respond
model
support
concept
genet
atopi
cytokin
dysregul
imbal
environment
factor
viru
infect
import
incept
asthmat
phenotyp
well
development
compon
contribut
respiratori
virus
common
caus
asthma
exacerb
asthmat
subject
differ
age
serolog
cultur
detect
method
virus
initi
indic
associ
asthma
despit
fact
detect
method
rel
insensit
virus
rhinoviru
rv
use
revers
transcript
polymeras
chain
reaction
rtpcr
assay
sensit
detect
rv
confirm
expand
initi
observ
inde
johnston
et
found
schoolag
children
acut
wheez
episod
test
posit
viru
use
rtpcr
standard
virolog
techniqu
viru
often
detect
rv
season
pattern
upper
respiratori
viru
infect
correl
close
hospit
admiss
asthma
particularli
pediatr
age
studi
indic
rv
infect
common
caus
asthma
exacerb
children
especi
spring
fall
similar
studi
perform
found
half
asthma
exacerb
associ
rv
infect
discuss
previous
infanc
atopi
may
defin
suscept
host
wheez
respiratori
infect
duff
et
exampl
studi
children
present
emerg
depart
wheez
children
year
age
like
respiratori
allergi
confirm
respiratori
viral
infect
compar
children
wheez
children
highest
risk
wheez
respiratori
allergi
respiratori
viral
infect
impli
respiratori
viral
infect
respiratori
allergi
may
synergist
effect
lower
airway
physiolog
enhanc
likelihood
wheez
respiratori
infect
children
less
year
age
wheez
also
note
risk
factor
wheez
quit
differ
infant
allerg
rsv
major
viral
isol
passiv
tobacco
smoke
exposur
major
risk
factor
wheez
avail
epidemiolog
data
children
adult
shown
episod
drop
peak
flow
measur
associ
rv
infect
found
correl
increas
asthma
symptom
nonspecif
airway
hyperrespons
follow
experiment
infect
asthmat
subject
studi
griinberg
et
demonstr
experiment
infect
lead
transient
drop
daili
home
record
fev
subject
asthma
variabl
airway
obstruct
correl
significantli
cold
symptom
asthma
symptom
increas
airway
hyperrespons
histamin
daili
variabl
fev
reflect
inflammatori
chang
within
airway
wall
induc
natur
rv
infect
follow
infect
influenza
studi
cheung
et
subject
mild
asthma
inocul
placebo
maxim
contractil
respons
inhal
methacholin
significantli
greater
infect
remain
elev
day
acut
infect
studi
indic
upper
respiratori
viral
infect
enhanc
reactiv
lower
airway
magnitud
bronchonstrict
chang
persist
week
acut
infect
respiratori
viral
infect
effect
lower
airway
respons
also
influenc
host
factor
particular
allerg
subject
experi
greater
chang
airway
respons
viral
infect
nonallerg
control
sb
j
e
c
furthermor
subject
lower
fev
valu
tend
greater
chang
airway
respons
viral
studi
suggest
effect
preexist
condit
allergi
intrins
lower
airway
function
calib
like
contribut
airway
hyperrespons
respiratori
viral
infect
potenti
mechan
viral
infect
could
potenti
caus
bronchoconstrict
increas
airway
respons
includ
enhanc
parasympathet
bronchoconstrict
respons
stimul
airway
sensori
nerv
interfer
bronchodilatori
function
nonadrenerg
noncholinerg
neuron
tabl
difficulti
assess
dysfunct
pulmonari
neural
regul
human
data
support
propos
mechan
deriv
anim
model
acut
respiratori
viral
infect
definit
pathway
human
depend
upon
develop
new
experiment
techniqu
inhibit
specif
neural
pathway
increas
bronchial
respons
found
normal
asthmat
subject
chang
small
airway
structur
function
may
also
contribut
significantli
sever
hyperinfl
ga
exchang
abnorm
note
acut
asthma
exacerb
maxim
airway
contractil
respons
methacholin
mild
asthmat
subject
increas
cold
probabl
secondari
excess
airway
narrow
attribut
airway
wall
thicken
airway
parenchym
uncoupl
abnorm
smooth
muscl
signific
chang
airway
morpholog
notic
anim
acut
viral
respiratori
ill
lead
mark
bronchiolar
narrow
plug
chang
includ
bronchiolar
airway
edema
cell
infiltr
epitheli
hyperplasia
fold
slough
airway
epitheli
surfac
addit
rat
mild
increas
pulmonari
resist
methacholin
sensit
acut
viral
respiratori
ill
evid
air
trap
ventilationperfus
latter
find
indic
virus
induc
signific
chang
peripher
airway
signific
function
outcom
absenc
mark
chang
measur
airway
obstruct
hyperrespons
respiratori
virus
caus
inflamm
injuri
healthi
airway
worsen
injuri
airway
alreadi
inflam
demonstr
asthma
respiratori
virus
induc
inflammatori
process
direct
cytopath
effect
airway
epithelium
eg
rsv
bronchiol
induc
immun
respons
stop
viral
replic
erad
viru
immun
respons
viral
infect
may
doubleedg
sword
howev
virusinduc
inflamm
also
contribut
airway
obstruct
respiratori
symptom
inde
although
mani
common
cold
virus
eg
rv
produc
signific
cytopath
effect
possibl
cell
infect
immunoinflammatori
respons
viru
probabl
major
caus
respiratori
symptom
section
associ
virusinduc
immun
respons
respiratori
symptom
explor
respiratori
virus
replic
primarili
airway
epitheli
cell
addit
serv
host
cell
well
document
epitheli
cell
also
initi
immun
respons
infect
secret
cytokin
chemokin
vitro
studi
epitheli
cell
cell
line
demonstr
respiratori
virus
rv
rsv
parainfluenzaviru
induc
secret
mani
differ
proinflammatori
cytokin
tnfa
gmcsf
chemokin
rant
mipla
lo
epithelialderiv
chemokin
like
import
signal
initi
antivir
respons
recruit
leukocyt
airway
support
concept
potent
neutrophil
chemoattract
found
high
level
nasal
secret
children
virusinduc
asthma
level
correl
number
airway
neutrophil
neutrophil
myeloperoxidas
level
suggest
neutrophil
activ
also
evid
howev
enhanc
airway
inflamm
caus
chemokin
secret
may
also
disturb
normal
airway
physiolog
chemokin
level
nasal
secret
correl
close
cold
symptom
exampl
level
correl
virusinduc
chang
airway
responi
v
e
n
e
level
epithelialderiv
cytokin
also
correl
respiratori
anim
studi
indic
overexpress
caus
bronchial
hyperresponsi
addit
stimul
cytokin
product
rv
upregul
epitheli
cell
surfac
express
intercellular
adhes
addit
facilit
cellcel
adhes
receptor
major
group
enhanc
express
adhes
protein
may
contribut
persist
sever
inflamm
asthmat
subject
possibl
greater
suscept
asthmat
children
cold
compar
nonasthmat
children
mechan
activ
cytokin
gene
epitheli
cell
adhes
molecul
investig
known
nuclear
factorlc
b
activ
import
virusinduc
transcript
regul
possibl
synthesi
varieti
inflammatori
cytkin
addit
nitric
oxid
may
regul
virusinduc
chemokin
product
posttranscript
mechan
inhibit
viral
repliat
although
clinic
studi
find
relationship
nitrat
level
nasal
secret
granulocyt
recruit
activ
seem
import
role
pathogenesi
virusinduc
asthma
exacerb
griinberg
et
exampl
experiment
inocul
atop
asthma
subject
either
placebo
found
neutrophil
count
peripher
blood
correl
cold
asthma
symptom
score
coldinduc
chang
airway
hyperrespons
addit
eosinophil
granular
protein
leukotrien
c
detect
nasal
secret
infant
children
virusinduc
wheez
l
l
n
es
e
increas
concentr
sputum
eosinophil
cation
protein
found
acut
phase
rv
infect
correl
increas
airway
respons
group
adult
asthma
experiment
inocul
vitro
experi
indic
rv
activ
eosinophil
diretli
like
inflammatori
mediat
cytokin
secret
virusactiv
cell
lung
contribut
eosinophil
activ
final
guinea
pig
infect
piv
develop
airway
eosinophil
airway
outcom
block
guinea
pig
pretreat
respiratori
virus
replic
quickli
within
day
inocul
quantiti
virus
viral
protein
suffici
activ
mononuclear
cell
airway
vitro
infect
human
monocyt
respiratori
virus
exampl
lead
potent
proinflammatori
cytokin
respons
releas
tnfcx
tnfa
increas
cell
recruit
airway
enhanc
adhes
molecul
express
endotheli
cell
addit
tnfa
associ
wheez
ill
develop
latephas
allerg
reaction
monocyt
macrophag
also
produc
interferon
inf
appear
nasal
secret
coincid
onset
recoveri
process
addit
cytokin
product
macrophag
incub
rsv
piv
produc
lipid
mediat
prostaglandin
e
plateletactiv
factor
thromboxan
augment
airway
inflamm
lymphocyt
includ
natur
killer
cell
cytotox
cell
cell
involv
limit
viral
replic
viral
clearanc
test
possibl
variat
lymphocyt
respons
might
account
variabl
abil
clear
viral
infect
parri
et
apo
measur
vitro
lymphocyt
respons
group
allerg
subject
inocul
rv
vigor
virusinduc
respons
lymphocyt
prolifer
ifn
secret
inocul
correl
reduc
viral
shed
inocul
result
suggest
factor
relat
host
cellular
respons
help
determin
degre
viral
replic
respiratori
viral
infect
character
host
factor
may
lead
new
therapeut
strategi
respiratori
infect
goal
particularli
import
peopl
asthma
sever
studi
shown
viral
infect
activ
wide
rang
cell
evid
come
experi
mice
cell
found
lung
acut
viral
infect
vitro
studi
human
peripher
blood
cell
express
earli
activ
marker
hour
cultur
rant
induc
respiratori
virus
high
concentr
also
induc
antigenindepend
tcell
activ
studi
suggest
respiratori
virus
induc
earli
nonspecif
tcell
activ
recruit
could
significantli
increas
intens
airway
inflamm
result
airway
dysfunct
respiratori
symptom
hypothesi
support
studi
volunt
infect
rhinoviru
respiratori
viru
infect
usual
caus
peripher
lymphopenia
increas
number
lymphocyt
upper
lower
airway
exampl
degre
peripher
blood
lymphopenia
lymphocyt
infiltr
airway
epithelium
correl
increas
airway
responsi
although
viral
infect
caus
similar
upper
respiratori
symptom
allerg
nonallerg
individu
loo
evid
interact
virusand
allergeninduc
respons
lower
airway
lemansk
colleag
exampl
identifi
patient
allerg
rhiniti
experiment
infect
viral
infect
increas
airway
reactiv
inhal
allergen
histamin
also
increas
frequenc
late
allerg
reaction
inhal
antigen
moreov
calhoun
colleag
use
bronchoscopi
studi
inflammatori
respons
allergen
individu
lung
segment
month
infect
rv
infect
enhanc
immedi
antigeninduc
releas
histamin
also
increas
recruit
eosinophil
lung
respiratori
infect
dual
effect
relat
asthma
first
increas
evid
sever
infect
rsv
piv
infanc
alter
lung
develop
physiolog
increas
risk
subsequ
wheez
asthma
second
infect
common
cold
virus
influenza
commonli
precipit
wheez
symptom
children
adult
alreadi
establish
asthma
rv
appear
import
viru
produc
exacerb
diseas
princip
mechan
occur
appear
viral
replic
epitheli
cell
trigger
cascad
inflamm
involv
granulocyt
macrophag
cell
secret
cytokin
mediat
inflammatori
process
although
essenti
clear
infect
augment
preexist
airway
inflamm
asthma
lead
increas
airway
obstruct
lower
respiratori
tract
symptom
greater
understand
virusinduc
chang
inflamm
correspond
chang
airway
physiolog
may
lead
new
therapeut
approach
treatment
prevent
virusinduc
airway
dysfunct
associ
radiolog
ascertain
pneumonia
age
year
asthmalik
symptom
pulmonari
function
childhood
prospect
studi
